Herman Mielants
#145,365
Most Influential Person Now
Herman Mielants's AcademicInfluence.com Rankings
Herman Mielantsphilosophy Degrees
Philosophy
#7797
World Rank
#11054
Historical Rank
Logic
#4834
World Rank
#6163
Historical Rank

Download Badge
Philosophy
Herman Mielants's Degrees
- PhD Rheumatology Ghent University
- Doctorate Medicine Ghent University
Why Is Herman Mielants Influential?
(Suggest an Edit or Addition)Herman Mielants's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Classification criteria for psoriatic arthritis: development of new criteria from a large international study. (2006) (2873)
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection (2009) (2650)
- HL-A AND INFECTIVE SACROILEITIS (1974) (2104)
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal (2009) (780)
- Assessment of enthesitis in ankylosing spondylitis (2003) (570)
- New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS) (2009) (510)
- Letter: HL-A and infective sacroileitis. (1974) (483)
- Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative (2008) (464)
- What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. (2004) (372)
- Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. (2002) (362)
- Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations (2004) (350)
- Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. (1999) (326)
- Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study (2000) (311)
- The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. (1995) (272)
- Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. (2000) (258)
- Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity (2000) (248)
- Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine (2008) (236)
- Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model (2012) (231)
- Crohn's disease associated with spondyloarthropathy: effect of TNF-α blockade with infliximab on articular symptoms (2000) (227)
- Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries (2002) (215)
- Ankylosing spondylitis and bowel disease. (2002) (206)
- Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? (2003) (197)
- Long-term evolution of gut inflammation in patients with spondyloarthropathy. (1996) (194)
- Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. (2001) (193)
- Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. (1990) (193)
- Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? (1999) (192)
- The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. (1995) (188)
- Ileocolonoscopic findings in seronegative spondylarthropathies. (1988) (176)
- Histopathology of intestinal inflammation related to reactive arthritis. (1987) (173)
- Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. (2007) (173)
- Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation? (2005) (154)
- Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy (2005) (150)
- Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis (2009) (149)
- Ileocolonoscopy in seronegative spondylarthropathy. (1989) (149)
- HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. (1985) (141)
- Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study (2011) (139)
- Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. (1991) (136)
- Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis (2005) (135)
- The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice (2007) (130)
- Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. (2005) (129)
- Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. (2004) (128)
- Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up (2002) (128)
- Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. (2008) (125)
- Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort (2013) (124)
- Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries (2003) (116)
- Bowel inflammation and the spondyloarthropathies. (1998) (115)
- Course of gut inflammation in spondylarthropathies and therapeutic consequences. (1996) (102)
- Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study (2012) (101)
- Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα (2001) (100)
- DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment (2005) (96)
- Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. (2005) (94)
- Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. (1995) (93)
- CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn’s disease (2004) (89)
- Colon mucosa of patients both with spondyloarthritis and Crohn’s disease is enriched with macrophages expressing the scavenger receptor CD163 (2004) (89)
- Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy (2004) (85)
- Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn’s disease (2004) (84)
- Determinants of hyperkyphosis in patients with ankylosing spondylitis (2005) (84)
- The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. (1995) (81)
- The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. (2004) (78)
- Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy (2003) (76)
- Gut inflammation and spondyloarthropathies (2002) (75)
- Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy--a prospective study. (1993) (75)
- A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. (1999) (74)
- Radiological scoring methods in ankylosing spondylitis: reliability and sensitivity to change over one year. (1999) (74)
- Costs of ankylosing spondylitis in three European countries: the patient’s perspective (2003) (74)
- Interpretation of ileal biopsies: morphological features in normal and diseased mucosa (2001) (72)
- Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease. (1991) (72)
- Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis. (1998) (66)
- Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo. (1988) (64)
- Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage. (2000) (63)
- Extra-articular manifestations. (2009) (61)
- Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy (2001) (61)
- Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity (2006) (60)
- Clinical and genetic factors associated with sacroiliitis in Crohn's disease (2007) (60)
- Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex (2000) (59)
- M‐cells are damaged and increased in number in inflamed human ileal mucosa (1993) (59)
- Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. (2006) (58)
- Spinal Radiographic Changes in Ankylosing Spondylitis: Association with Clinical Characteristics and Functional Outcome (2009) (57)
- An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis (2006) (57)
- Clinical survey of and pathogenic approach to para-articular ossifications in long-term coma. (1975) (57)
- Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience (2002) (56)
- Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order (2004) (56)
- A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology. (1993) (54)
- A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis (2004) (54)
- The gut in the spondyloarthropathies. (1990) (54)
- HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation. (1987) (50)
- Involvement of the zygapophyseal joint in ankylosing spondylitis: relation to the bridging syndesmophyte. (1999) (50)
- ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version (2008) (49)
- The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome (2001) (49)
- HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis. (1985) (49)
- The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis. (2006) (45)
- Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis (2002) (45)
- Repeat ileocolonoscopy in reactive arthritis. (1987) (44)
- Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity. (1999) (43)
- Subclinical involvement of the gut in undifferentiated spondylarthropathies. (1989) (43)
- Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration. (1979) (42)
- Prevalence of inflammatory rheumatic diseases in an adolescent urban student population, age 12 to 18, in Belgium. (1993) (41)
- LEVAMISOLE-INDUCED ADVERSE REACTIONS IN HLA B27-POSITIVE RHEUMATOID ARTHRITIS (1978) (41)
- Letter: Levamisole in rheumatoid arthritis. (1976) (41)
- How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? (2007) (40)
- Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis. (1998) (39)
- Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers. (2000) (39)
- Cervical spine involvement in rheumatoid arthritis: a clinical, neurological and radiological evaluation. (1994) (39)
- Intestinal mucosal permeability in inflammatory rheumatic diseases (1992) (38)
- Gout and its relation to lipid metabolism. I. Serum uric acid, lipid, and lipoprotein levels in gout. (1973) (38)
- Late onset pauciarticular juvenile chronic arthritis: relation to gut inflammation. (1987) (38)
- Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis (2002) (38)
- Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distance. (2004) (38)
- Sulfasalazine treatment in juvenile chronic arthritis: an open study. (1991) (37)
- Mucosal Inflammation in Spondylarthritides: Past, Present, and Future (2011) (36)
- Gut inflammation in the spondyloarthropathies (2005) (36)
- Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs. (1991) (35)
- Avascular necrosis and its relation to lipid and purine metabolism. (1975) (34)
- Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience. (2002) (34)
- A cross‐sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis (2014) (34)
- Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope (2006) (34)
- Altered gut transcriptome in spondyloarthropathy (2006) (33)
- The zygapophyseal joint determines morphology of the enthesophyte. (2000) (33)
- Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis (1982) (32)
- Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review (2014) (32)
- The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study. (1991) (32)
- CARD15 polymorphisms are associated with anti‐Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients (2005) (32)
- Understanding Limitations in At-work Productivity in Patients with Active Ankylosing Spondylitis: The Role of Work-related Contextual Factors (2015) (31)
- Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis. (2005) (31)
- Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy. (1990) (30)
- The role of gut inflammation in the pathogenesis of spondyloarthropathies. (1996) (30)
- Immune linkages between inflammatory bowel disease and spondyloarthropathies. (2002) (30)
- Interactions between gut inflammation and arthritis/spondylitis (2010) (30)
- A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations. (1978) (28)
- Destructive lesions of small joints in seronegative spondylarthropathies: relation to gut inflammation. (1990) (28)
- Immunoglobulin containing cells in terminal ileum and colorectum of patients with arthritis related gut inflammation. (1988) (27)
- Candida Glabrata Arthritis: Case Report and Review of the Literature of Candida Arthritis (1999) (27)
- AGRANULOCYTOSIS, LEVAMISOLE, AND HLA-B27 (1977) (26)
- Healthcare consumption and direct costs of rheumatoid arthritis in Belgium (2005) (26)
- Expression of T cell receptors αβ and γδ in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy (1992) (25)
- Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease. (1998) (24)
- INFLAMMATION OF THE ILEUM IN PATIENTS WITH B27-POSITIVE REACTIVE ARTHRITIS (1984) (24)
- Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin. (2001) (24)
- Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo (2006) (23)
- Levamisole as basic treatment of rheumatoid arthritis: longterm evaluation. (1981) (23)
- Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor α (2001) (23)
- Long-term functional results of the non-surgical treatment of common bacterial infections of joints. (1982) (22)
- Idiopathic inflammatory bowel diseases: immunological hypothesis. (1994) (22)
- Comparison of serum salicylate levels and gastro-intestinal blood loss between salsalate (Disalcid)and other forms of salicylates. (1981) (22)
- Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation. (2003) (22)
- CARD 15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn ’ s disease (2004) (22)
- The intimate relationship between gut and joint in spondyloarthropathies (2007) (21)
- Non-Hodgkin's lymphoma presenting with spinal involvement (2000) (20)
- Review article: bone and joint diseases in inflammatory bowel disease. (1998) (20)
- M-cells are damaged and increased in number in inflamed human ileal mucosa. (1994) (19)
- Anti-TNF-alpha therapy in ankylosing spondylitis. (2006) (19)
- NSAID AND THE LEAKY GUT (1985) (19)
- Association between ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: reality or fiction? (1996) (19)
- LEVAMISOLE IN RHEUMATOID ARTHRITIS (1976) (19)
- Leflunomide and methotrexate combination therapy in daily clinical practice (2006) (19)
- Destructive hip lesions in seronegative spondyloarthropathies: relation to gut inflammation. (1990) (18)
- The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface. (2003) (18)
- Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis. (1978) (18)
- HLA and juvenile chronic polyarthritis. (2008) (18)
- Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation (2000) (17)
- Evaluation of the involvement of axial entheses and sacroiliac joints in relation to diagnosis: Comparison among diffuse idiopathic skeletal hyperostostis (DISH), osteoarthrosis and ankylosing spondylitis (1992) (17)
- Rheumatoid factor and serum IgG, IgM and IgA levels in rheumatoid arthritis with vasculitis. (1976) (16)
- Bilateral spontaneous pneumothorax in a patient with pulmonary rheumatoid nodules, secondary infected by Aspergillus (2007) (16)
- Strontium 87m scanning of the sacroiliac joints in ankylosing spondylitis. (1972) (16)
- Subclinical gut inflammation in spondyloarthritis is associated with a pro-angiogenic intestinal mucosal phenotype (2011) (16)
- Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies. (1984) (16)
- A Nationwide Survey on Patient’s versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study (2016) (16)
- Bone scintigraphy of the hands in early stage lupus erythematosus and rheumatoid arthritis. (1997) (16)
- HLA-B27 positive idiopathic acute anterior uveitis: a unique manifestation of subclinical gut inflammation. (1990) (16)
- Increased intestinal permeability in ankylosing spondylitis. (1992) (16)
- Current use of biologicals for the treatment of spondyloarthropathies (2001) (15)
- Is 99mTc human immunoglobulin G scintigraphy (HIG-scan) useful for the detection of spinal inflammation in ankylosing spondylitis? (2000) (15)
- Reliability of self assessed joint counts in ankylosing spondylitis (2002) (14)
- Gout and its relation to lipid metabolism. II. Correlations between uric acid, lipid, and lipoprotein levels in gout. (1973) (13)
- The effect of low doses of prednisolone on T-cell subsets in rheumatoid arthritis. (1987) (13)
- Contextual factors influence work outcomes in employed patients with ankylosing spondylitis starting etanercept: 2-year results from AS@Work (2018) (12)
- Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis (2005) (12)
- ILEAL INFLAMMATION IN B27-POSITIVE REACTIVE ARTHRITIS (1984) (12)
- Clinical manifestations in HLA-B27-positive patients. (1987) (12)
- Peripheral blood T lymphocyte subpopulations determined by monoclonal antibodies in active rheumatoid arthritis. (1986) (12)
- Simultaneous occurrence of diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis in the same patient. (1992) (11)
- Peripheral blood T lymphocytes subpopulations in HLA-B7 related rheumatic diseases: ankylosing spondylitis and reactive synovitis. (1983) (11)
- Disease manifestations of progressive systemic sclerosis: sensitivity and specificity (1987) (11)
- Enteropathic arthritis, uveitis, Whipple's disease, and miscellaneous spondyloarthropathies. (1993) (10)
- Spondylarthropathies: from gut to target organs. (1996) (10)
- Familial aggregation in seronegative spondyloarthritis of enterogenic origin. A family study. (1986) (10)
- Are syndesmophytes most prevalent in the lumbar or in the cervical spine in patients with ankylosing spondylitis and do they develop in a specific direction? (2012) (10)
- The bowel and spondylarthritis: a clinical approach (1998) (10)
- High Prevalence of Undiagnosed Axial Spondyloarthritis in Patients with Chronic Low Back Pain Consulting Non-Rheumatologist Specialists in Belgium: SUSPECT Study (2017) (9)
- Influence of the gut and cytokine patterns in spondyloarthropathy. (2002) (9)
- Quantitative assessment of foot structure in rheumatoid arthritis by a foot digitizer: Detection of deformities even in the absence of erosions (2012) (9)
- Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis. (2004) (9)
- Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study. (1987) (9)
- BRUCELLAR SPONDYLODISCITIS: CASE REPORT (2007) (8)
- Clinical and genetic factors associated with sacroi liitis in Crohn's disease (2008) (8)
- Recombinant interferon gamma in rheumatoid arthritis. A double-blind study comparing immuneron (recombinant interferon gamma) with placebo (1988) (8)
- Structure-Modifying Capacity of Anti-Tumour Necrosis Factor-α Therapy in Ankylosing Spondylitis (2012) (8)
- Changes in antinuclear serology in patients with spondylarthropathy under sulphasalazine treatment. (1993) (8)
- CARD15 mutations in patients with spondyloarthropathy are linked with disease progression and evolution to Crohn's disease (2003) (8)
- Intervention with immunomodulatory agents: new pharmacological developments (1992) (7)
- Polyarteritis Nodosa Mimicking Polymyalgia Rheumatica (1999) (7)
- B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. (1979) (7)
- Current concepts in psoriatic arthritis. (1994) (7)
- Spondylarthropathy and gut inflammation: immunopathogenetic mechanisms. (1992) (6)
- A challenging case of septic sacroiliitis with psoas involvement (2014) (6)
- Gastrointestinal tract and rheumatic disease (1998) (6)
- Immunoregulatory changes in autoimmune disease. (1983) (6)
- Thymic hormones and interferons in the treatment of rheumatoid arthritis. (1988) (6)
- Expression of T cell receptors alpha beta and gamma delta in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy. (1992) (6)
- Osteomyelitis in a patient with a chronically infected arterial graft and longstanding hypertrophic osteoarthropathy of the leg. (1991) (6)
- Significance of gut inflammation in the seronegative spondyloarthropathies. (1987) (6)
- Long-term evolution of patients with spondylarthropathy and gut inflammation (1994) (6)
- Sensitivity and specificity of criteria for spondyloarthritis in children with late onset pauciarticular juvenile chronic arthritis as well as their characteristics. (2009) (6)
- Clinical and radiographic features of Reiter's syndrome and inflammatory bowel disease related to arthritis. (1990) (6)
- [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies]. (1996) (5)
- Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists (2010) (5)
- Long-term evaluation of intermittent levamisole treatment in rheumatoid arthritis (1977) (5)
- OP0056 Tnf-alpha blockade with infliximab in patients with active spondyloarthropathy: follow-up of one year maintenance regimen (2001) (5)
- Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with E 7 integrin (2002) (5)
- Influence of low dose corticosteroid administration on the lymphocytes subpopulations. (1982) (5)
- Spondyloarthropathies: progress and challenges. (2008) (5)
- Ileal mucosal mononuclear cells in patients with seronegative spondylarthropathy. (1990) (5)
- Macroscopic and histological changes of the ileum HLA-B27 related diseases: therapeutic consequences. (1984) (5)
- Increased number of macrophages in non-inflamed colon of patients with spondyloarthropathy, a human model of early Crohn's disease (2000) (5)
- B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. (1979) (4)
- Ileitis in the spondylarthropathies (1997) (4)
- Analysis of telomere length as predictive marker in psoriasis for comorbidities (2016) (4)
- Reduced metallothionein expression in colonic Crohn's disease: evidence for it new disease-modifying gene (2008) (4)
- Clinical observations programme in SpA: disease parameters, treatment options and practical management issues (2008) (4)
- Prevalence of clinical and subclinical spondyloarthropathy in patients with inflammatory bowel disease (1998) (4)
- Clinical assessment in the spondyloarthropathies. (2009) (4)
- The effect of infliximab on skin lesions in a patient with scleroderma (CREST) (2004) (4)
- T cell cytokines in gut mucosa of patients with spondyloarthropathy reflect immune alterations in Crohn's disease (1999) (4)
- Inflammatory Bowel Disease Spondyloarthritis: Epidemiology, Clinical Features, and Treatment (2006) (4)
- Clinical assessment in the spondyloarthropathies, including psoriatic arthritis (2006) (4)
- Enthesopathy of the heels in juvenile onset seronegative B27 positive spondyloarthropathy. (1986) (4)
- Intestinal mucosa of patients with spondyloarthropathy is enriched with T cells carrying alpha E beta 7 integrin, even in the absence of histologically defined inflammation (1999) (3)
- Ileocolonoscopy and spondarthritis. (1988) (3)
- Belgian patients with familial and sporadic ankylosing spondylitis differ in disease phenotype (2006) (3)
- Side-effects of levamisole: recent aspects (1987) (3)
- Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification? (2005) (3)
- [A study of the loss of occult blood by the method of radioactive chrome during treatment with acetylsalicylic acid. Effect of enclosure in cellulose acetylphthalate]. (1975) (3)
- Juvenile spondyloarthropathies in 1992. (1993) (2)
- Association between ASCA-positivity and carrier of a CARD-15 mutation in patients with Crohn's disease (2003) (2)
- Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio products. (2009) (2)
- Immunopathogenetic mechanisms in spondylarthropathy and gut inflammation. (1995) (2)
- Rapidly growing gastric metastasis of Merkel cell carcinoma, an unusual cause of melena (2016) (2)
- Eular workshop on Rheumatology Research (1982) (2)
- T.9. Systemic Levels of IL-23 are Strongly Associated with Disease Activity in Rheumatoid Arthritis but not Spondyloarthritis (2009) (2)
- HLA and juvenile chronic polyarthritis. (1976) (2)
- A genetic acro-osteolysis syndrome. A Hajdu-Cheney syndrome. (1978) (2)
- Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Attrition and long-term clinical effect (2006) (2)
- Second conference on spondylarthropathies and the gut. (1994) (2)
- 2nd Conference on spondylarthropathies and the gut, Gent, Belgium, 1-2 July 1993 (1994) (2)
- Reflections on the link between intestinal permeability and inflammatory joint disease. (1990) (2)
- Clinical aspects of enterogenic arthropathies (1997) (2)
- Agreement between evidence and Belgian rheumatologists' experience on the use of DMARDs for arthritis and/or enthesitis in ankylosing spondylitis (2008) (2)
- Cervical septic spondylodiscitis in association with diffuse idiopathic skeletal hyperostosis. (1999) (2)
- Salicylate-induced occult gastrointestinal blood loss: comparison between different oral and parenteral forms of acetylsalicylates and salicylates (1984) (2)
- Longterm evaluation of intermittent levamisole treatment in rheumatoid arthritis. (1977) (2)
- Arthritis and abdominal symptoms (1994) (1)
- not spondyloarthritis with disease activity in rheumatoid arthritis but Systemic levels of IL-23 are strongly associated (2010) (1)
- To be or not to be rheumatologist: survey among Belgian medical students and internal medicine trainees: what do certified rheumatologists think about the current rheumatology training program? (2017) (1)
- Hajdu-Cheney syndrome. (2001) (1)
- Agreement between evidence and Belgian rheumatologists' experience on HLA B27 determination in patients with specific imaging features in ankylosing spondylitis (2008) (1)
- Lymphocyte sub-population counts after a single 40 mg administration of piroxicam in 20 patients with rheumatoid arthritis (1984) (1)
- [Early referral of first line patients suspected of axial spondyloarthritis: the Belgian results of the RADAR study]. (2012) (1)
- Lymphoepithelial interactions in human terminal ileum and colon : Electron-microscopic findings in normal and inflamed mucosa (1989) (1)
- Comparing 2 referral strategies to diagnose axial spondyloarthritis: the recognizing and diagnosing ankylosing spondylitis reliably study (2011) (1)
- International Congress on Spondyloarthropathies (2008) (1)
- Short and long term synovial immunumodulation by etanercept in spondyloarthropathy (2005) (1)
- Images in rheumatology: cervical septic spondylodiscitis in association with diffuse idiopathic skeletal hyperostosis. (1999) (1)
- M2045 Reduced Metallothionein Expression in Colonic Crohn's Disease: Evidence for a New Disease-Modifying Gene (2008) (1)
- Intrications of connective tissue diseases. (1978) (1)
- Crohn's disease patients with CARD15 variants have higher risk of developing axial joint involvement (2003) (1)
- Third Eular Workshop on Rheumatology Research (1983) (1)
- Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years (2005) (1)
- ISSAS: International Start TNF-blocker Study in Ankylosing Spondylitis (2004) (1)
- Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition. (2006) (1)
- Intra-articular treatment of inflammatory arthritis: Double-blind trial comparing bufexamac with methylprednisolone acetate (1987) (1)
- Upregulation of E-cadherin and associated molecules (α-, β-, and γ-catenins) in inflammed bowel mucosa (1998) (1)
- Bowel inflammation in rheumatic diseases: Trigger or consequence (2005) (1)
- Effective immunomodulation of peripheral joint pathology in spondyloarthropathy by etanercept (2005) (1)
- Influence of longterm administration of levamisole on total lymphocyte and T cell subsets in rheumatoid arthritis. (1984) (1)
- The SF-6D differentiates less in the lower ranges of the patient's utility when compared with the EQ-5D but has a better reliability and sensitivity to change (2005) (1)
- Strontium 87mscanning ofthesacroiliac joints inankylosing spondylitis (1972) (1)
- Interferon-Gamma in the treatment of rheumatoid arthritis (1996) (1)
- Effects of chemical agents and enzymes on the detection of lymphocyte surface markers. (1998) (0)
- Isolation of colonie mucosal lamina propria and intra-epithelial lymphocytes: mechanical versus enzymatic isolation (1998) (0)
- Inflammatory arthropathy and inflammatory bowel disease (1999) (0)
- [Osteopoikilosis. 3 cases. Association with rheumatoid polyarthritis]. (1971) (0)
- Prediction models for disease: The effect of associations between markers on calculating the risk for disease by likelihood ratio products in SpA (2008) (0)
- A double-blind study to determine the duration of action of flurbiprofen in a sustained release preparation. (1993) (0)
- Spondylarthropathy and the gut : the pathologist's contribution (1993) (0)
- [Nonsurgical treatment of infectious arthritis caused by commonplace bacteria]. (1976) (0)
- Clinical Characteristics and Functional Outcome Spinal Radiographic Changes in Ankylosing Spondylitis : Association with DEWULF (2009) (0)
- The zygoapophyseal joint decides on the morphology of the enthesiophytes (1996) (0)
- Relative increase of IL-10 producing peripheral blood T lymphocytes after anti-TNF-A chimeric antibody (infliximab) treatment in fistulizing Crohn's disease (2000) (0)
- Gastrointestinal blood loss after intake of benoxaprofen (1982) (0)
- Effects of anti-tumor necrosis factor alpha on synovium in patients with spondylarthropathy: Comment on the article by Baeten et al - Reply. (2001) (0)
- T-Cell Subpopulations in Peripheral Blood and Synovial Fluid in Rheumatic Diseases (1984) (0)
- opinion including uncertainty appraisal (part I): classification of paper patients by expert classification criteria for axial spondyloarthritis SpondyloArthritis international Society The development of Assessment of (2009) (0)
- Contents, Vol. 189, Supplement 2, 1994 (1994) (0)
- Comparison of different permeability probes in patients with spondylarthropathy and noninflammatory rheumatic disease: What is the effect of NSAIDs? (1998) (0)
- Gut inflammation and rheumatology (1996) (0)
- Evaluation of dual-energy absorptiometry (DXA) procedures for densitometry of hand bones in vitro and vivo (1992) (0)
- Gut involvement in the spondyloarthritides (2010) (0)
- Immunohistological studies of IL-2 receptor in normal and inflamed ileal mucosa (1992) (0)
- Different cytokine profiles in peripheral blood and mucosal T lymphocytes of normal controls, Crohn's disease and ulcerative colitis patients (2000) (0)
- First International Congress on Spondyloarthropathies, September 22-28, 1998, Gent, Belgium (1998) (0)
- High frequency of 'missed' HLA-B loci by serologic determination in patients with spondyloarthropathy and chronic gut inflammation (1999) (0)
- Ileocolonoscopy in patients with spondylarthropathy (1993) (0)
- [Current findings on the immunological monitoring of patients with rheumatoid arthritis]. (1984) (0)
- I n fluence of the gut and cytokine pat t e rns in spondy l o a rt h ro p at hy (2002) (0)
- Mechanical isolation of human intestinal intraepithelial and lamina propria lymphocytes (1998) (0)
- Rheumatic disorders in a HLA B27 positive population. (1979) (0)
- [Joint manifestations of enteropathies]. (1993) (0)
- Disease evolution in spondylarthropathy patients in relation to their gut histology on ileocolonoscopy (1993) (0)
- SAT0274 High frequency of microscopic gut inflammation in axial and peripheral spondyloarthritis: The giant cohort (2013) (0)
- Rheumatic disorders in a HLA B27 positive population. (1979) (0)
- Inflammatory bowel disease and subclinical gut inflammation in spondyloarthropathy patients are associated with increased expression of the E-cadherin/catenin complex (1999) (0)
- Maljor histocompatibili ty complex class IIantigen (HLA-DR)expression byileal epithelial cells in patients withseronegative spondylarthropathy (2011) (0)
- [The non-surgical treatment of common bacterial infections of joints (author's transl)]. (1976) (0)
- Clinical responsetotherapy withthymopoietin pentapeptide (TP-5) inrheumatoid arthritis (1982) (0)
- IX Eular Workshop for Rheumatology Research (1989) (0)
- SAT0235 Determinants of productivity costs in as. comparative study in the netherlands, france and belgium (2001) (0)
- Spondyloarthropathies, involvement of the gut : proceedings of the First Conference on Spondyloarthropathies, Involvement of the Gut, Ghent, 10-13 September 1986 (1987) (0)
- Long-term (up to 8 years) evaluation of side-effects of gold salts, levamisole and D-penicillamine in rheumatoid arthritis patients (1987) (0)
- Sulfasalazine in "intractable" rheumatoid arthritis. (1987) (0)
- [Levamisole used in rheumatoid arthritis]. (1979) (0)
- Review of immunotherapy in rheumatoid arthritis (1980) (0)
- SpondyloArthritis international Society (ASAS) exercise by experts from the Assessment of patients with chronic back pain: a real patient New criteria for inflammatory back pain in (2009) (0)
- Clinical aspects of spondylarthritis: what is new ? (1995) (0)
- Rheumatological manifestations of the enteropathies (1997) (0)
- CHAPTER 88 – Spondyloarthropathies (2009) (0)
- Molecular concepts in the approach to therapy (1992) (0)
- T-cell receptors in ileal mucosal biopsies of patients with Crohn disease and spondylarthropathy. (1992) (0)
- A RED FACE IN A LUPUS PATIENT: THINKING BEYOND LUPUS RASH (2010) (0)
- Effects of chemical agents and enzymes on lymphocyte surface markers (1999) (0)
- [HL-A and chronic juvenile polyarthritis]. (1976) (0)
- Radiological sacroiliitis is linked with CARD15 gene polymorphisms in patients with Crohn's disease (2004) (0)
- Evaluation of the DAS28 at week 14 or week 22 correlates best with long term attrition to infliximab therapy in rheumatoid arthritis patients (2006) (0)
- Crohn's disease and ulcerative colitis show different distribution patterns of CD83 positive dendritic cells (1999) (0)
- Increased expression of E 7 integrin in uninflamed mucosa of patients with spondyloarthropathy (1998) (0)
- [Relationship between avascular necrosis and lipid and purine metabolisms]. (1975) (0)
- Prognostic factors in the evolution of spondylarthropathies (1995) (0)
- [Hematologic side effects of levamisole in the treatment of rheumatoid arthritis]. (1979) (0)
- How to evaluate the DAS28 in patients with a false high score for reasons other than rheumatoid arthritis disease activity (2006) (0)
- Gut inflammation in the spondylarthropathies : relation to the clinical expression of the disease and possible mechanisms (1992) (0)
- EXPRESSION IN COLONIC CROHN'S DISEASE: EVIDENCE FOR A NEW DISEASE-MODIFYING GENE STUDY OF MUCOSAL ANTIMICROBIAL PEPTIDES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND AFTER (2008) (0)
- Long-term follow-up in the treatment of rheumatoid arthritis with levamisole. (1981) (0)
- Management of early inflammatory arthritis. Intervention with immunomodulatory agents: new pharmacological developments. (1992) (0)
- [New prospects of immunotherapy in rheumatoid polyarthritis]. (1990) (0)
- Flow cytometric determination of cytokine profile of peripheral blood and mucosal T lymphocytes in patients with fistulizing and non-fistulizing Crohn's disease (2000) (0)
- THU0365 Work Productivity in a Cohort of Employed Ankylosing Spondylitis Patients Treated with Etanercept (2013) (0)
- Chapter 18 – Enteric Infections and Arthritis (2007) (0)
- Modeling the probability for rheumatoid arthritis during diagnostic work-up: How to combine the results of ACPA, RF and HLA-SE testing? (2006) (0)
- A Comparison of TNF Dependent and Independent Features of Murine Spondyloarthropathy (2007) (0)
- Influence of NSAID on intestinal permeability is dependent on the type of underlying rheumatic disease (1998) (0)
- Diagnostic performance and predictive value of serum markers for the diagnosis of rheumatoid arthritis (2004) (0)
- Ankylosing Spondylitis. Edited by M. Dougados and D. van der Heijde. £12.00. Oxford, Health Press, 2004. 84 pp. ISBN 1-903734-44-4. (2004) (0)
- Radiological sacroiliitis in Crohn's disease: A multicenter association study (2006) (0)
- Ileitis in rheumatic diseases (1995) (0)
- Assessment of agreement of expert opinion on clinical features in axial spondyloarthritis (SpA) (2005) (0)
- DAS28 is a robust measure of the physician's clinical judgment of response infliximab therapy (2005) (0)
- Occurrence and 2-year progression of syndesmophytes in a prevalence cohort of patients with ankylosing spondylitis (AS) (2005) (0)
- Arthritis, osteoporosis and rheumatologic manifestations: patterns, diagnostic and therapeutic problems (1998) (0)
- [Determination of immunoglobulins G, M and A in synovial fluid]. (1971) (0)
- Which patients with ankylosing spondylitis start anti-TNF-alpha therapy in daily clinical practice? (2006) (0)
- Second conference on spondylarthropathies and the gut - meeting report (1994) (0)
- AB0233 Productivity costs in as. comparison among 3 european countries (2001) (0)
- Parameters contributing to inflammatory back pain (IBP) according to experts (2005) (0)
- Clinical trials on the efficacy and toxicity of slow acting antirheumatic drugs. (1984) (0)
- INCREASED INTESTINAL PERMEABILITY IN ANKYLOSING SPONDYLITIS. AUTHOR'S REPLY (1992) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Herman Mielants?
Herman Mielants is affiliated with the following schools: